Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva

European Journal of Haematology

Volumn 73, Issue 4, 2004, Pages 258-262

  Nückel, Holger ^a,b   Meller, Daniel ^a   Steuhl, Klaus Peter ^a   Dührsen, Ulrich ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Anti CD20 monoclonal antibody; Conjunctiva; Extranodal marginal zone lymphoma of mucosa associated lymphoid tissue type; Rituximab

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; RITUXIMAB;

ADULT; AGED; ARTICLE; BLEPHARITIS; CANCER RADIOTHERAPY; CASE REPORT; CATARACT; CHEMOSIS; CONJUNCTIVA TUMOR; CONJUNCTIVITIS; COST EFFECTIVENESS ANALYSIS; CRYOTHERAPY; DIPLOPIA; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHEMA; EXTRANODAL MARGINAL ZONE LYMPHOMA; FEMALE; FLU LIKE SYNDROME; HEPATITIS B; HUMAN; HUMAN TISSUE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RELAPSE; TREATMENT CONTRAINDICATION; VIRUS REACTIVATION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CONJUNCTIVAL NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; RECURRENCE;

EID: 4644353978     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00299.x     Document Type: Article

References (34)

1. ISAACSON PG, WRIGHT DH. Malignant lymphoma of mucosa-associated lymphoid tissue. Cancer 1983;52:1410-1416.
2. WOTHERSPOON AC, ORTIZ-HIDALGO C, FALZON MR, ISAACSON PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-1176.
3. HYJEK E, SMITH WJ, ISAACSON PG. Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum Pathol 1988;19:766-776.
4. HYJEK E, ISAACSON PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol 1988;19:1315-1326.
5. ZUCCA E, CONCONI A, PEDRINIS E et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003;101:2489-2495.
6. LE QT, EULAU SM, GEORGE TI, HILDEBRAND R, WARNKE RA, DONALDSON SS, HOPPE RT. Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys 2002;52:657-663.
7. BHATIA S, PAULINO AC, BUATTI JM, MAYR NA, WEN BC. Curative radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys 2002;54:818-823.
8. DUNBAR SF, LINGGOOD RM, DOPPKE KP, DUBY A, WANG CC. Conjunctival lymphoma: results and treatment with a single anterior electron field. A lens sparing approach. Int J Radiat Oncol Biol Phys 1990;19:249-257.
9. HAINSWORTH JD, LITCHY S, BURRIS HA Jr et al. Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma. Rituximab: the first monoclonal antibody approved for the treatment of lymphoma. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II studyIDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. J Clin Oncol 2002;20:4261-4267.
10. MCLAUGHLIN P, GRILLO-LOPEZ AJ, LINK BK et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 1998;16:2825-2833.
11. MALONEY DG, GRILLO-LOPEZ AJ, BODKIN DJ, WHITE CA, LILES TM, ROYSTON I, YARNS C, ROSENBERG J, LEVY R. IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. J Clin Oncol 1997;15:3266-3274.
12. COIFFIER B. Immunochemotherapy: the new standard in aggressive non-Hodgkin's lymphoma in the elderly. Semin Oncol 2003;30(Suppl. 2):21-27.
13. COIFFIER B, HAIOUN C, KETTERER N et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 1998;92:1927-1932.
14. HAINSWORTH JD, LITCHY S, BARTON JH, HOUSTON GA, HERMANN RC, BRADOF JE, GRECO FA. Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network. J Clin Oncol 2003;21:1746-1751.
15. LIN TS, LUCAS MS, BYRD JC et al. Rituximab in B-cell chronic lymphocytic leukaemia. Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network. Rituximab in chronic lymphocytic leukemia. Emerging information on the use of rituximab in chronic lymphocytic leukemia. Rituximab therapy of patients with B-cell chronic lymphocytic leukemia. Semin Oncol 2003;30:483-492.
16. MONTSERRAT E. Rituximab in chronic lymphocytic leukemia. Semin Oncol 2003;30(Suppl. 2):34-39.
17. KEATING MJ, O'BRIEN S, ALBITAR M. Emerging information on the use of rituximab in chronic lymphocytic leukemia. Semin Oncol 2002;29(Suppl. 2):70-74.
18. HUHN D, VON SCHILLING C, WILHELM M et al. Rituximab therapy of patients with B-cell chronic lymphocytic leukemia. Blood 2001;98:1326-1331.
19. COIFFIER B. Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma. Semin Oncol 2002;29(Suppl. 6):18-22.
20. CZUCZMAN MS, GRILLO-LOPEZ AJ, WHITE CA, SALEH M, GORDON L, LOBUGLIO AF, JONAS C, KLIPPENSTEIN D, DALLAIRE B, VARNS C. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 1999;17:268-276.
21. CONCONI A, MARTINELLI G, THIEBLEMONT C et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003;102:2741-2745.
22. BALDINI L, BLINI M, GUFFANTI A, FOSSATI V, COLOMBI M, LA TARGIA ML, BERTONI F, ALIETTI A, NERI A, BERTONI G. Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa. Ann Oncol 1998;9:779-781.
23. ZINZANI PL, MAGAGNOLI M, GALIENI P et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 1999;17:1254.
24. KOBAYASHI A, TAKAHIRA M, YAMADA A, SEGAWA Y, TANAHASHI T, SHIRAO Y, NONOMURA A. Fornix and conjunctiva reconstruction by amniotic membrane in a patient with conjunctival mucosa-associated lymphoid tissue lymphoma. Jpn J Ophthalmol 2002;46:346-348.
25. EICHLER MD, FRAUNFELDER FT. Cryotherapy for conjunctival lymphoid tumors. Am J Ophthalmol 1994;118:463-167.
26. BLASI MA, GHERLINZONI F, CALVISI G, SASSO P, TANI M, CELLINI M, BALESTRAZZI E. Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report. Ophthalmology 2001;108:559-562.
27. BELLESI G, DI LOLLO S, BOSI A, BERNARDI F, CAMPANA G, ROMAGNANI S, ROSSI FP. Primary conjunctival lymphoma: response to chemotherapy in 4 cases. Acta Haematol 1982;68:161-162.
28. UNO T, ISOBE K, SHIKAMA N, NISHIKAWA A, OGUCHI M, UENO N, ITAMI J, OHNISHI H, MIKATA A, ITO H. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multi-institutional, retrospective review of 50 patients. Cancer 2003;98:865-871.
29. KUHNT T, WOLLSCHLAGER B, BLOCKING M, KRAUSE U, DUNST J. Extranodal non-Hodgkin's lymphoma of MALT-type stage I. A case report. Strahlen ther Onkol 2003;179:396-400.
30. XICOY B, RIBERA JM, ARELLANO A, MATE JL, MILLA F, FELIU E. Effectiveness of local radiotherapy in primary extranodal marginal zone B-cell lymphoma of MALT or MALT lymphoma of conjunctiva: study of four cases. Leuk Lymphoma 2002;43:1975-1977.
31. LEE SW, SUH CO, KIM GE, YANG WI, LEE SY, HAHN JS, PARK JO. Role of radiotherapy for primary orbital lymphoma. Am J Clin Oncol 2002;25:261-265.
32. ERICKSON BA, HARRIS GJ, ENKE CA, MURRAY KJ, MASSARO BM, HANSON GA, HANSEN RM, ANDERSON T, WILSON JF. Periocular lymphoproliferative diseases: natural history, prognostic factors, and treatment. Radiology 1992;185:63-70.
33. LACHAPELLE KR, RATHEE R, KRATKY V, DEXTER DF. Treatment of conjunctival mucosa-associated lymphoid tissue lymphoma with intralesional injection of interferon alfa-2b. Arch Ophthalmol 2000;118:284-285.
34. CELLINI M, POSSATI GL, PUDDU P, CARAMAZZA R. Interferon alpha in the therapy of conjunctival lymphoma in an HIV+ patient. Eur J Ophthalmol 1996;6:475-477.